Can You Take Ashwagandha and Smoke Weed?

No clinical trial has tested the combination of ashwagandha and cannabis together, so there is no definitive safety profile for the pairing. What does exist is a handful of case reports, some overlapping pharmacology that raises legitimate concerns, and enough indirect evidence to make the combination worth thinking carefully about rather than dismissing or panicking over. The short version: many people probably do combine them without obvious harm, but the lack of research is not the same as proof of safety, and at least one documented case links the two substances to a serious vascular event in the brain.

How Each Substance Works on the Brain

Understanding why combining these two matters starts with what each one does on its own. Ashwagandha, an adaptogenic herb used for centuries in Ayurvedic medicine, has direct activity on GABA receptors in the brain. Lab research using mammalian brain tissue showed that an aqueous extract of ashwagandha root activated GABAA channels, the same receptors targeted by drugs like benzodiazepines and alcohol. The extract was also a potent activator of GABAρ1 receptors, which were roughly 27 times more sensitive to ashwagandha than the standard GABAA type.¹ GABA is the brain’s primary inhibitory neurotransmitter. When its receptors are activated, neural activity slows down, producing calm, drowsiness, and sometimes sedation.

Cannabis works through a different system but lands in some of the same territory. THC, the main psychoactive compound in marijuana, acts on the endocannabinoid system, which modulates the central nervous system and inflammatory pathways. CBD, the other well-known cannabis compound, has been suggested to have anxiety-reducing properties. THC is more complicated: depending on dose, how you consume it, and your individual biology, it can either ease anxiety or intensify it.² Low doses tend to be calming; higher doses, especially in people who are sensitive or inexperienced, can trigger paranoia and racing thoughts.

The practical concern here is additive sedation. Both substances push the brain toward a more inhibited, calmer state through different mechanisms. Stacking two calming agents can amplify drowsiness, slow reaction times, and impair coordination more than either would alone. If you’ve ever mixed alcohol with an antihistamine and felt far more impaired than you expected, the principle is similar. The risk isn’t necessarily dangerous for everyone, but it’s real enough that combining them before driving or operating anything requiring sharp attention is a bad idea.

Do They Interfere with Each Other’s Metabolism?

One of the biggest concerns when combining any two substances is whether one changes how the liver processes the other. If substance A slows down the liver enzyme that breaks down substance B, blood levels of B can spike unexpectedly. THC is metabolized primarily by liver enzymes in the CYP family, particularly CYP3A4 and CYP2C9. If ashwagandha strongly inhibited CYP3A4, you’d worry about THC sticking around longer than expected.

On this front, the news is relatively reassuring. A study using human liver microsomes found that crude extracts and active compounds from ashwagandha showed no significant interaction with either CYP3A4 or CYP2D6.³ That doesn’t rule out every possible metabolic interaction, since the study didn’t test CYP2C9 specifically, and lab-dish results don’t always translate perfectly to what happens in a living human body. But it does suggest ashwagandha is unlikely to dramatically alter how quickly your liver clears THC from your system. The two substances appear to be largely metabolically independent of each other.

This is worth putting in context: the absence of a liver enzyme clash doesn’t mean the combination is safe. Plenty of drug interactions happen through pharmacodynamic pathways, meaning two substances affecting the same brain systems simultaneously, rather than through metabolic interference. The overlapping sedation described above is exactly that kind of interaction, and it doesn’t require one substance to change the blood levels of the other.

The Case Report That Raised Red Flags

The most concerning piece of evidence linking ashwagandha and cannabis comes from case reports of reversible cerebral vasoconstriction syndrome, or RCVS. This is a condition where blood vessels in the brain suddenly narrow, causing severe “thunderclap” headaches and, in serious cases, stroke-like symptoms. RCVS has a long list of known triggers, including certain drugs and supplements that affect blood vessel tone.

A 2023 case report described RCVS developing in a patient who was consuming both ashwagandha and cannabis. The authors suggested that certain components of ashwagandha may have vasoactive or sympathomimetic effects, meaning they can influence blood vessel constriction, and that these effects could trigger cerebral vasoconstriction in people who are already predisposed.⁴ Cannabis itself, particularly THC, is independently listed as a potential RCVS trigger. So the question becomes whether the combination carries a higher risk than either alone.

A single case report is the weakest form of clinical evidence. It shows that something happened in one person under specific circumstances, and the patient in question was also taking other substances. You can’t draw population-level conclusions from it. But RCVS is rare enough and serious enough that the report matters as a signal. If you have a history of severe headaches, migraines with aura, or any prior vascular events, the combination deserves extra caution. For the average healthy person, this case report is worth knowing about but probably not worth losing sleep over.

What Happens to Your Stress Hormones

People often take ashwagandha specifically to lower cortisol, the hormone most associated with the body’s stress response. A systematic review of human trials examining how plants and phytonutrients affect the hypothalamic-pituitary-adrenal axis, the hormonal chain that governs cortisol release, found that the most consistent result across studies was a morning cortisol-lowering effect from ashwagandha supplementation.⁵ That review also noted significant variability in study designs, so the size of the cortisol drop varies from study to study. Still, the direction is consistent: ashwagandha tends to blunt cortisol production.

Cannabis also affects cortisol, though the relationship is messier. Acute THC exposure can temporarily raise cortisol, while chronic use tends to flatten the cortisol response over time. If you’re using ashwagandha to manage stress and also smoking regularly, the two may partly cancel each other out acutely, or they may reinforce a blunted cortisol profile with chronic use. Neither outcome is well-characterized by research. What’s clear is that both substances are tinkering with the same hormonal axis, and the net result depends on dosing, timing, and your body’s baseline.

One practical note: if you feel unusually flat, emotionally numb, or drained, it may be worth considering whether a chronically suppressed cortisol response is part of the picture. Cortisol gets a bad reputation as the “stress hormone,” but you need it to wake up in the morning, mount an immune response, and maintain energy throughout the day. Driving it too low, whether through supplements or habits or both, can leave you feeling worse than the stress you were trying to treat.

Liver Safety with Ashwagandha

Most discussions about combining ashwagandha with cannabis focus on the brain, but the liver deserves attention too. In recent years, cases of liver damage linked to ashwagandha supplements have been reported in Japan, Iceland, India, and the United States. One documented case involved a patient admitted to the hospital with jaundice after taking ashwagandha for a year. Lab work showed elevated bilirubin, liver enzymes (ALT, AST), and other markers consistent with drug-induced liver injury.⁶

These cases are rare relative to the millions of people who take ashwagandha, but they highlight a real risk that gets glossed over in the supplement marketing. The liver injury appears to be idiosyncratic, meaning it doesn’t happen in a predictable, dose-dependent way but instead hits certain susceptible individuals. Cannabis adds another layer of concern here because chronic, heavy cannabis use has its own modest associations with liver stress, particularly in people with preexisting liver conditions or those who use alcohol as well. If you’re taking ashwagandha daily and smoking frequently, your liver is metabolizing both substances continuously. Neither one is particularly hepatotoxic for most people, but stacking two substances that each have some liver risk, however small, in someone who also drinks alcohol or takes other medications is the kind of cumulative load that physicians worry about.

If you’re combining the two and notice symptoms like unexplained fatigue, dark urine, yellowing of the eyes or skin, or upper-right abdominal discomfort, those warrant prompt medical evaluation. Liver problems from supplements tend to be caught late because people don’t associate an herbal product with organ damage.

Thyroid and Endocrine Disruption

Beyond cortisol, ashwagandha has broader endocrine activity that can become relevant when you’re also using cannabis. A critical review of ashwagandha’s adverse effects found that its endocrine-modulating activity has been implicated in thyrotoxicosis, a condition where thyroid hormone levels rise too high, and in adrenal suppression.⁷ These are not common outcomes, but they’ve been documented clearly enough that the herb can no longer be considered hormonally inert.

Cannabis has its own endocrine fingerprint. Regular use is associated with changes in testosterone, luteinizing hormone, and prolactin levels, though the magnitude and clinical significance of these shifts are debated. Thyroid effects from cannabis are less well-documented, but the endocannabinoid system has receptors in thyroid tissue, meaning the potential for interaction exists at a biological level even if clinical evidence is thin.

The reason this matters practically: if you’re taking ashwagandha for its adaptogenic or hormone-balancing properties, and you’re also a regular cannabis user, the hormonal environment you’re creating is more complex than either substance alone would produce. Symptoms of thyroid overactivity, like unexplained weight loss, rapid heartbeat, tremor, or feeling wired despite being tired, shouldn’t be brushed off as anxiety or too much caffeine. They may warrant a thyroid panel, especially if ashwagandha has been in the mix for several months.

Timing, Dosing, and Practical Considerations

Since no clinical guideline exists for combining these substances, practical advice has to lean on general pharmacological principles and common sense. A few things are worth considering if you decide to use both:

• Stagger them: Taking ashwagandha in the morning and smoking in the evening spreads out the sedative load rather than stacking it. Many ashwagandha users take it with breakfast anyway, and this approach lets you feel each substance’s effects more distinctly.
• Start low: If you’ve been taking ashwagandha and want to add cannabis, or vice versa, begin with a lower dose of the new substance than you might otherwise use. The additive calming effect can catch people off guard, especially with edibles, which hit harder and last longer than smoking.
• Watch for excessive drowsiness: If the combination makes you significantly more sedated than either one alone, that’s a sign the pharmacodynamic overlap is meaningful for your body. Adjust accordingly.
• Be honest with your doctor: If you take prescription medications, particularly sedatives, thyroid drugs, blood pressure medications, or psychiatric medications, the three-way interaction potential goes up substantially. Your doctor can’t assess interactions they don’t know about.

Supplement quality is another often-ignored variable. Ashwagandha products vary widely in concentration, extraction method, and purity. A standardized root extract at a well-known concentration is not the same thing as a cheap capsule of dried root powder from an unverified supplier. Similarly, cannabis potency and cannabinoid ratios differ enormously between products and strains. Two people “combining ashwagandha and weed” may be exposing their bodies to very different chemical loads depending on the specifics of what they’re actually consuming.

Who Should Be Most Cautious

Most of the specific risks flagged above, the RCVS case, the liver injury reports, the thyroid disruption, involve people who were either predisposed to the problem or using ashwagandha for extended periods. Certain groups should take the combination more seriously than others:

People with a history of liver disease or heavy alcohol use face a higher baseline risk of liver injury from supplements. Adding cannabis metabolism on top of daily ashwagandha use increases the workload on an already compromised organ. If you fall into this category, periodic liver function tests are a reasonable precaution, especially if you plan to take ashwagandha for more than a few months.

Anyone with thyroid disorders should approach ashwagandha cautiously in general. The herb’s ability to modulate thyroid hormone levels means it can interfere with thyroid medication dosing, and the endocrine complexity added by regular cannabis use makes monitoring more important.⁷

People prone to severe headaches or migraines, particularly migraines with aura, should pay attention to the RCVS signal. Both ashwagandha and cannabis have vascular effects, and while one case report is far from proof, RCVS is serious enough that the cautious move is to avoid stacking two possible triggers.

Pregnant or breastfeeding individuals should avoid both substances, though for different reasons. Ashwagandha has traditionally been classified as potentially abortifacient in high doses in Ayurvedic texts, and cannabis use during pregnancy is associated with lower birth weight and developmental concerns. The combination amplifies uncertainty in a context where uncertainty is least acceptable.

Why the Research Gap Exists

It might seem odd that two widely used substances have never been studied together in a controlled trial. The reasons are partly regulatory and partly cultural. Cannabis remains a Schedule I substance under U.S. federal law, which makes any clinical trial involving it logistically difficult and expensive. Ashwagandha, as a dietary supplement, doesn’t go through the FDA approval process that would generate the kind of safety data pharmaceutical drugs require. The intersection of the two falls into a regulatory no-man’s-land where neither the drug-development pipeline nor the supplement industry has an incentive to fund research.

This means the people generating the most real-world data on this combination are the users themselves, and they’re doing so without any systematic way to report outcomes or track adverse events. Online forums are full of anecdotal reports ranging from “it’s the most relaxing combination I’ve found” to “I got dizzy and my heart raced.” Anecdotes are a starting point for hypotheses, not a substitute for controlled evidence. Until the regulatory landscape shifts enough to allow proper study, anyone combining ashwagandha and cannabis is essentially running an unmonitored experiment on themselves, which is worth acknowledging even if you ultimately decide the combination works for you.